Unknown

Dataset Information

0

Potential surrogate endpoints for overall survival in locoregionally advanced nasopharyngeal carcinoma: an analysis of a phase III randomized trial.


ABSTRACT: The gold standard endpoint in trials of locoregionally advanced nasopharyngeal carcinoma (NPC) is overall survival (OS). Using data from a phase III randomized trial, we evaluated whether progression-free survival (PFS), failure-free survival (FFS), distant failure-free survival (D-FFS) or locoregional failure-free survival (LR-FFS) could be reliable surrogate endpoints for OS. Between July 2002 and September 2005, 316 eligible patients with stage III-IVB NPC were randomly assigned to receive either radiotherapy alone or chemoradiotherapy. 2- and 3-year PFS, FFS, D-FFS, and LR-FFS were tested as surrogate endpoints for 5-year OS using Prentice's four criteria. The Spearman's rank correlation coefficient was calculated to assess the strength of the associations. After a median follow-up time of 5.8 years, 2- and 3-year D-FFS and LR-FFS were not significantly different between treatment arms, in rejection of Prentice's second criterion. Being consistent with all Prentice's criteria, 2- and 3-year PFS and FFS were valid surrogate endpoints for 5-year OS; the rank correlation coefficient was highest (0.84) between 3-year PFS and 5-year OS. In conclusion, PFS and FFS at 2 and 3 years may be candidate surrogate endpoints for OS at 5 years; 3-year PFS may be more appropriate for early assessment of long-term survival.

SUBMITTER: Chen YP 

PROVIDER: S-EPMC4518214 | biostudies-other | 2015

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC9239497 | biostudies-literature
| S-EPMC7301660 | biostudies-literature
| S-EPMC6059121 | biostudies-literature
| S-EPMC4443445 | biostudies-literature
| S-EPMC6804912 | biostudies-literature
| S-EPMC7244479 | biostudies-literature
| S-EPMC4131693 | biostudies-literature
| S-EPMC8693416 | biostudies-literature
| S-EPMC3328614 | biostudies-literature
| S-EPMC5330705 | biostudies-literature